Some clinical features of the combination of diabetes mellitus and COVID-19


DOI: https://dx.doi.org/10.18565/therapy.2022.4suppl.46-49

Elizarova I.O., Chernykh T.M., Zoloyedov V.I.

Voronezh State Medical University named after N.N. Burdenko, Voronezh, Russian Federation
Abstract. The most important challenge to modern medicine has become COVID-19 infection, which causes multiple organ lesions, including disorders of carbohydrate metabolism. The article presents the results of scientific observations on the effect of the SARS-CoV-2 virus on the course of diabetes mellitus.
Keywords: COVID-19, clinical features, diabetes mellitus
Read entire article

Literature

1. Зайратьянц О.В., Cамсонова М.В., Михалева Л.М. с соавт. Патологическая анатомия COVID-19: атлас. Под ред. О.В. Зайратьянца. М.: ГБУ «НИИОЗММ ДЗМ». 2020; 140 с.


2. Вопросы оказания медицинской помощи населению в условиях распространения новой коронавирусной инфекции COVID-19. Методическое пособие. Под ред. В.М. Иванова, Т.Н. Петровой. Воронеж. 2021; 525 с.


3. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 15 от 22.02.2022. Минздрав России. Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/ВМР_COVID-19_V15.pdf (дата обращения – 04.04.2022).


4. Эндокринопатии и COVID-19. Неотложные состояния, их профилактика и лечение. ФГБУ «НМИЦ эндокринологии» Минздрава России. Доступ: https://www.endocrincentr.ru/sites/default/files/all/news2020/COVID_REC/Эндокринопатии%20и%20COVID-19.%20Неотложные%20состояния%C2%A0их%20профилактика%20и%20лечение.pdf (дата обращения – 04.04.2022).


5. Misra A., Ghosh A., Gupta R. Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification. Diabetes Metab Syndr. 2021; 15(1): 403–6. doi: 10.1016/j.dsx.2021.01.018.


6. Rabbone I., Schiaffini R., Cherubini V., Scaramuzza A. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020; 43 (11): 2870–72. doi: 10.2337/dc20-1321.


7. Lawrence C., Seckold R., Smart C. et al. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic. Diabet Med. 2021; 38(1): e14417. doi: 10.1111/dme.14417.


8. Gregory J.M., Slaughter J.C., Duffus S.H. et al. COVID-19 severity is tripled in the diabetes community: A prospective analysis of the pandemic’s impact in type 1 and type 2 diabetes. Diabetes Care. 2021; 44(2): 526–32. doi: 10.2337/dc20-2260.


Similar Articles

Back to Content

Бионика Медиа